News for AC Immune Stock (ACIU)

AC Immune (ACIU) Surges 43% in the Past 3 Months: Here's Why

Zacks Investment Research • 09/05/23

AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023

GlobeNewsWire • 09/05/23

AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research • 08/04/23

AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

GlobeNewsWire • 08/04/23

AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023

GlobeNewsWire • 07/28/23

AC Immune SA Appoints New Chief Medical Officer

GlobeNewsWire • 07/26/23

AC Immune Showcasing Precision Medicine Programs at AAIC 2023

GlobeNewsWire • 07/03/23

Why Shares of AC Immune Jumped This Week

The Motley Fool • 06/30/23

Trading Penny Stocks With Limited Capital: 3 Tops Tips

PennyStocks • 06/28/23

AC Immune's stock soars 13% after FDA grants fast-track designation to Alzheimer's treatment

Market Watch • 06/27/23

AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer's Disease

GlobeNewsWire • 06/27/23

AC Immune Holds Annual General Meeting of Shareholders

GlobeNewsWire • 06/23/23

AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update

GlobeNewsWire • 04/28/23

7 Biotech Stocks With Huge Return Potential for Long-Term Investors

InvestorPlace • 04/27/23

AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer's Disease

GlobeNewsWire • 04/05/23

AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline

GlobeNewsWire • 03/20/23

AC Immune: Dementia-Focused Swiss Biotech With A Sad History Of Failures

Seeking Alpha • 03/18/23

AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update

GlobeNewsWire • 03/16/23

AC Immune to Report Full Year 2022 Financial Results and Provide Corporate Update on March 16, 2023

GlobeNewsWire • 03/08/23

AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43

GlobeNewsWire • 02/07/23

AC Immune to Present at the SVB Securities Global Biopharma Conference

GlobeNewsWire • 02/02/23

AC Immune's ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer's Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial

GlobeNewsWire • 01/26/23

AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer's Disease

GlobeNewsWire • 01/18/23

Why I've Added A Full Position In AC Immune To My Tax Loss Selling Basket

Seeking Alpha • 12/27/22

AC Immune's Alzheimer's Disease Vaccine-candidate ACI-35.030 Selected for Further Development

GlobeNewsWire • 11/30/22